Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AmerisourceBergen Still Bullish On Medicare Rx; Part B Changes Pinch

Executive Summary

AmerisourceBergen expects to feel a negative impact from the changes in oncology reimbursement under Medicare Part B in 2005

You may also be interested in...



Bristol Exiting Oncology Distribution Business Ahead Of Part B Pinch

Bristol-Myers Squibb has signed an agreement to sell its Oncology Therapeutics Network unit prior to the 2005 reimbursement changes for chemotherapy drugs under the Medicare Rx law

Bristol Exiting Oncology Distribution Business Ahead Of Part B Pinch

Bristol-Myers Squibb has signed an agreement to sell its Oncology Therapeutics Network unit prior to the 2005 reimbursement changes for chemotherapy drugs under the Medicare Rx law

ABC Goes To D.C.: Former Amgen Exec Norton Will Head Government Affairs

AmerisourceBergen is opening a Washington, D.C. government affairs office led by former Amgen VP Rita Norton

Related Content

Topics

UsernamePublicRestriction

Register

SC143384

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel